D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Chemistry D-index 48 Citations 7,355 262 World Ranking 9462 National Ranking 14

Research.com Recognitions

Awards & Achievements

Fellow of the Royal Society of South Africa

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Organic chemistry
  • Biochemistry

Kelly Chibale spends much of his time researching Stereochemistry, Plasmodium falciparum, Pharmacology, In vitro and Malaria. His Stereochemistry research incorporates elements of Combinatorial chemistry, Quinoline, Chemical synthesis and Antimycobacterial. His Plasmodium falciparum study combines topics from a wide range of disciplines, such as Biochemistry, Structure–activity relationship, Cysteine protease and Cytotoxicity.

The Pharmacology study combines topics in areas such as Chloroquine, Artemisinin, In vivo and Plasmodium berghei. His studies deal with areas such as Chalcone and Strain as well as In vitro. His Malaria research incorporates themes from Environmental health, Virology, African trypanosomiasis, Drug resistance and Drug discovery.

His most cited work include:

  • Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi. (205 citations)
  • Design, synthesis and in vitro antimalarial evaluation of triazole-linked chalcone and dienone hybrid compounds (135 citations)
  • Exploring the potential of xanthene derivatives as trypanothione reductase inhibitors and chloroquine potentiating agents (132 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Plasmodium falciparum, Stereochemistry, Pharmacology, In vitro and Biochemistry. Kelly Chibale works mostly in the field of Plasmodium falciparum, limiting it down to topics relating to Structure–activity relationship and, in certain cases, Parasite hosting, as a part of the same area of interest. His Stereochemistry research includes themes of Antimycobacterial, Quinoline and Chemical synthesis.

His study in Pharmacology is interdisciplinary in nature, drawing from both Metabolite, Hemozoin, In vivo and Plasmodium berghei. His studies in In vitro integrate themes in fields like Mode of action and Strain. His study looks at the relationship between Biochemistry and fields such as Mycobacterium tuberculosis, as well as how they intersect with chemical problems.

He most often published in these fields:

  • Plasmodium falciparum (47.09%)
  • Stereochemistry (37.22%)
  • Pharmacology (34.68%)

What were the highlights of his more recent work (between 2017-2021)?

  • Plasmodium falciparum (47.09%)
  • Malaria (20.25%)
  • In vivo (17.72%)

In recent papers he was focusing on the following fields of study:

Kelly Chibale mainly investigates Plasmodium falciparum, Malaria, In vivo, Pharmacology and Drug discovery. The various areas that Kelly Chibale examines in his Plasmodium falciparum study include Mode of action, Chloroquine, Benzimidazole and Cytotoxicity. His research ties Stereochemistry and Cytotoxicity together.

His Malaria research is multidisciplinary, incorporating perspectives in Humanized mouse and Virology. His research in In vivo intersects with topics in Multiple drug resistance, In vitro, ADME, hERG and Kinase. Kelly Chibale combines subjects such as Intensive care medicine, Druggability, Artemisinin, Computational biology and Drug with his study of Drug discovery.

Between 2017 and 2021, his most popular works were:

  • UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria. (76 citations)
  • Dihydroartemisinin inhibits prostate cancer via JARID2/miR-7/miR-34a-dependent downregulation of Axl. (30 citations)
  • Recent updates in the discovery and development of novel antimalarial drug candidates. (30 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Organic chemistry
  • Catalysis

His primary scientific interests are in Plasmodium falciparum, Drug discovery, Malaria, Pharmacology and Microsome. The study incorporates disciplines such as Combinatorial chemistry, Chloroquine, Stereochemistry and Quinoline in addition to Plasmodium falciparum. Borrowing concepts from Bioorganometallic chemistry, Kelly Chibale weaves in ideas under Stereochemistry.

His research integrates issues of Humanized mouse and Drug in his study of Malaria. He interconnects Mediator, Kinase and In vivo in the investigation of issues within Pharmacology. His Microsome study integrates concerns from other disciplines, such as Mechanism of action, Structure–activity relationship and Mycobacterium tuberculosis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi.

Doron C. Greenbaum;Zachary Mackey;Elizabeth Hansell;Patricia Doyle.
Journal of Medicinal Chemistry (2004)

307 Citations

Design, synthesis and in vitro antimalarial evaluation of triazole-linked chalcone and dienone hybrid compounds

Eric M. Guantai;Kanyile Ncokazi;Timothy J. Egan;Jiri Gut.
Bioorganic & Medicinal Chemistry (2010)

206 Citations

Exploring the potential of xanthene derivatives as trypanothione reductase inhibitors and chloroquine potentiating agents

Kelly Chibale;Mark Visser;Donelly van Schalkwyk;Peter J Smith.
Tetrahedron (2003)

205 Citations

Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives

Idan Chiyanzu;Cailean Clarkson;Peter J. Smith;Julie Lehman.
Bioorganic & Medicinal Chemistry (2005)

182 Citations

The state of the art in anti-malarial drug discovery and development.

Jeremy N. Burrows;Kelly Chibale;Timothy N.C. Wells.
Current Topics in Medicinal Chemistry (2011)

182 Citations

Synthesis, antimalarial and antitubercular activity of acetylenic chalcones

Renate H. Hans;Eric M. Guantai;Carmen Lategan;Peter J. Smith.
Bioorganic & Medicinal Chemistry Letters (2010)

182 Citations

Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain.

Idan Chiyanzu;Elizabeth Hansell;Jiri Gut;Philip J. Rosenthal.
Bioorganic & Medicinal Chemistry Letters (2003)

163 Citations

Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery.

Moses Hohman;Kellan Gregory;Kelly Chibale;Peter J. Smith.
Drug Discovery Today (2009)

143 Citations

Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase

Tanya Paquet;Claire Le Manach;Diego González Cabrera;Yassir Younis.
Science Translational Medicine (2017)

134 Citations

3,5-Diaryl-2-aminopyridines as a Novel Class of Orally Active Antimalarials Demonstrating Single Dose Cure in Mice and Clinical Candidate Potential

Yassir Younis;Frederic Douelle;Tzu-Shean Feng;Diego Gonzalez Cabrera.
Journal of Medicinal Chemistry (2012)

130 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Kelly Chibale

Sean Ekins

Sean Ekins

University of Arizona

Publications: 56

Philip J. Rosenthal

Philip J. Rosenthal

University of California, San Francisco

Publications: 43

Christophe Biot

Christophe Biot

University of Lille

Publications: 39

Marcel Kaiser

Marcel Kaiser

Swiss Tropical and Public Health Institute

Publications: 29

Peter Smith

Peter Smith

University of Aberdeen

Publications: 29

Vicky M. Avery

Vicky M. Avery

Griffith University

Publications: 22

Elizabeth A. Winzeler

Elizabeth A. Winzeler

University of California, San Diego

Publications: 22

David A. Fidock

David A. Fidock

Columbia University

Publications: 19

Sergio Wittlin

Sergio Wittlin

Swiss Tropical and Public Health Institute

Publications: 19

Milena Botelho Pereira Soares

Milena Botelho Pereira Soares

Oswaldo Cruz Foundation

Publications: 18

Laurent Kremer

Laurent Kremer

Inserm : Institut national de la santé et de la recherche médicale

Publications: 18

Shabana I. Khan

Shabana I. Khan

University of Mississippi

Publications: 16

Antoniana U. Krettli

Antoniana U. Krettli

Oswaldo Cruz Foundation

Publications: 16

Antony J. Williams

Antony J. Williams

Environmental Protection Agency

Publications: 14

Yann Guérardel

Yann Guérardel

University of Lille

Publications: 13

Reto Brun

Reto Brun

Swiss Tropical and Public Health Institute

Publications: 13

Trending Scientists

Jeffrey F. Morris

Jeffrey F. Morris

City College of New York

Hagai Cohen

Hagai Cohen

Weizmann Institute of Science

Shaffique Adam

Shaffique Adam

National University of Singapore

Costas Panayiotou

Costas Panayiotou

Aristotle University of Thessaloniki

Jianmin Qu

Jianmin Qu

Tufts University

Ying-Hui Fu

Ying-Hui Fu

University of California, San Francisco

Santiago P. Aubourg

Santiago P. Aubourg

Spanish National Research Council

Patrick Kitabgi

Patrick Kitabgi

Inserm : Institut national de la santé et de la recherche médicale

Françoise Portaels

Françoise Portaels

Institute of Tropical Medicine Antwerp

Per O.J. Hall

Per O.J. Hall

University of Gothenburg

Lotfi Aleya

Lotfi Aleya

Centre national de la recherche scientifique, CNRS

Alexander I. Shiklomanov

Alexander I. Shiklomanov

University of New Hampshire

Song-Hai Shi

Song-Hai Shi

Tsinghua University

Jing Ma

Jing Ma

St. Jude Children's Research Hospital

Herman Mielants

Herman Mielants

Ghent University Hospital

P. D'Avanzo

P. D'Avanzo

National Institute for Astrophysics

Something went wrong. Please try again later.